Display options
Share it on

Front Cell Neurosci. 2017 May 03;11:127. doi: 10.3389/fncel.2017.00127. eCollection 2017.

Nitric Oxide Synthase Inhibitor Attenuates the Effects of Repeated Restraint Stress on Synaptic Transmission in the Paraventricular Nucleus of the Rat Hypothalamus.

Frontiers in cellular neuroscience

Magdalena Kusek, Anna Tokarska, Marcin Siwiec, Anna Gadek-Michalska, Bernadeta Szewczyk, Grzegorz Hess, Krzysztof Tokarski

Affiliations

  1. Department of Physiology, Institute of Pharmacology, Polish Academy of SciencesKraków, Poland.
  2. Institute of Zoology and Biomedical Research, Jagiellonian UniversityKraków, Poland.
  3. Department of Neurobiology, Institute of Pharmacology, Polish Academy of SciencesKraków, Poland.

PMID: 28515682 PMCID: PMC5413825 DOI: 10.3389/fncel.2017.00127

Abstract

Corticotropin-releasing hormone (CRH)-synthesizing parvocellular neuroendocrine cells (PNCs) of the hypothalamic paraventricular nucleus (PVN) play a key role in the activation of the hypothalamic-pituitary-adrenocortical (HPA) axis. Several studies have demonstrated that synaptic inputs to these cells may undergo stress-related enhancement but, on the other hand, it has been reported that exposition to the same stressor for prolonged time periods may induce a progressive reduction in the response of the HPA axis to homotypic stressors. In the present study rats were subjected to 10 min restraint sessions, repeated twice daily for 3 or 7 days. Miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs) were then recorded from PNCs in

Keywords: GABAergic; HPA; PVN; corticosterone; glutamatergic; mEPSC; mIPSC; stress

References

  1. J Neurosci. 1999 Sep 1;19(17):7640-7 - PubMed
  2. Int J Dev Neurosci. 1998 Jun-Jul;16(3-4):241-60 - PubMed
  3. Neuroscience. 1997 Apr;77(3):623-7 - PubMed
  4. J Physiol. 2017 Jan 18;:null - PubMed
  5. Nat Neurosci. 2010 Oct;13(10 ):1257-64 - PubMed
  6. Pharmacol Rep. 2012;64(6):1381-90 - PubMed
  7. Neurosci Biobehav Rev. 2015 Sep;56:35-49 - PubMed
  8. Br J Pharmacol. 2002 Mar;135(5):1079-95 - PubMed
  9. Expert Opin Ther Targets. 2008 Jun;12(6):717-27 - PubMed
  10. Psychoneuroendocrinology. 2011 Apr;36(3):406-14 - PubMed
  11. Neuroscience. 2006;138(4):1067-81 - PubMed
  12. Nat Rev Neurosci. 2015 Jul;16(7):377-88 - PubMed
  13. J Neurosci. 2003 Jun 15;23(12):4850-7 - PubMed
  14. Nat Rev Neurosci. 2015 Jan;16(1):5-16 - PubMed
  15. Eur J Neurosci. 2010 Nov;32(10 ):1715-25 - PubMed
  16. Biol Psychiatry. 2012 Feb 15;71(4):301-8 - PubMed
  17. Front Endocrinol (Lausanne). 2016 Oct 31;7:137 - PubMed
  18. J Neurochem. 2010 May;113(3):563-75 - PubMed
  19. J Neuroendocrinol. 2002 Dec;14(12):929-32 - PubMed
  20. Neuroscience. 1995 May;66(2):247-52 - PubMed
  21. Behav Brain Res. 2012 Dec 1;235(2):176-81 - PubMed
  22. J Physiol Pharmacol. 2013 Oct;64(5):565-70 - PubMed
  23. Eur J Neurosci. 2004 Sep;20(6):1665-73 - PubMed
  24. Eur J Neurosci. 2005 Jan;21(1):113-21 - PubMed
  25. Neuroscience. 2010 Oct 27;170(3):773-81 - PubMed
  26. Eur Neuropsychopharmacol. 2013 Nov;23(11):1611-22 - PubMed
  27. Amino Acids. 2008 Jun;35(1):17-27 - PubMed
  28. Pharmacol Rep. 2011;63(6):1393-403 - PubMed
  29. Pharmacol Rep. 2013;65(5):1163-75 - PubMed
  30. J Physiol. 2011 Sep 1;589(17):4259-70 - PubMed
  31. Front Cell Neurosci. 2012 May 11;6:24 - PubMed
  32. Nat Neurosci. 2009 Apr;12(4):438-43 - PubMed
  33. Integr Comp Biol. 2002 Jul;42(3):541-51 - PubMed
  34. J Comp Neurol. 2009 Nov 10;517(2):156-65 - PubMed
  35. Endocrinology. 2007 Nov;148(11):5496-506 - PubMed
  36. Brain Res. 2003 Dec 12;993(1-2):230-4 - PubMed
  37. Endocrinology. 2016 Jun;157(6):2346-55 - PubMed

Publication Types